Argentum Medical sale to BioDerm
Other07/02/2023
Shore sold Argentum Medical to BioDerm, a Mountaingate Capital portfolio company. The transaction closed January 31, 2023. BioDerm, rather than Mountaingate itself, was the identified operating acquirer.
Type
Other
Announced
07/02/2023
Amount
Financial data requires access
Asset class
Private Equity
Reported parties
Shore Capital Partners,Argentum Medical,BioDerm,Mountaingate Capital